跳到正文
原文
Journal of Clinical Oncology 临床肿瘤· Ariel E. Marciscano·· 2026-10-08AI 评分61

生物学特征重于单药治疗:EORTC 22033-26033 成熟结果重申分子分层而非治疗顺序决定低级别胶质瘤预后

Biology Over Monotherapy: Mature Results From European Organisation For Research and Treatment of Cancer 22033-26033 Reaffirm Molecular Stratification, Not Treatment Sequence, Defines Prognosis in Low-Grade Glioma

AI 导读

Journal of Clinical Oncology 刊发 Ariel E. Marciscano 的评论,围绕 EORTC 22033-26033 的成熟结果讨论低级别胶质瘤预后判断。文章重申分子分层而非治疗顺序决定预后,并强调生物学特征重于单药治疗。

来源:Journal of Clinical Oncology 临床肿瘤 · ascopubs.org